Revance Therapeutics, Inc. Human Resources Contracts & Agreements
57 Contracts & Agreements
- Bonus & Incentive Agreements (21 contracts)
- Compensation Agreements (11)
- Employment Agreements (14)
- Separation Agreements (5)
- Severance Agreements (6)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2024)
- Separation Agreement dated February 23, 2024 by and between Revance Therapeutics, Inc. and Dustin Sjuts (Filed With SEC on February 28, 2024)
- Amended and Restated Executive Severance Benefit Plan (Filed With SEC on February 13, 2024)
- Separation Agreement dated February 25, 2022 by and between Revance Therapeutics, Inc. and Abhay Joshi (Filed With SEC on May 10, 2022)
- Separation Agreement (Filed With SEC on February 28, 2022)
- Revance Therapeutics, Inc. 2022 Management Bonus Plan (Filed With SEC on February 28, 2022)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 10, 2021)
- Revance Therapeutics, Inc. 2021 Management Bonus Plan (Filed With SEC on February 25, 2021)
- Form of Restricted Stock Bonus Agreement and Grant Notice for Revance Therapeutics, Inc. 2014 Equity Incentive Plan (Filed With SEC on February 25, 2021)
- Executive Employment Agreement effective July 23, 2020 by and between Revance Therapeutics, Inc. and Aubrey Rankin (Filed With SEC on November 9, 2020)
- Executive Employment Agreement dated February 17, 2020 by and between Revance Therapeutics, Inc. and Dwight Moxie (Filed With SEC on February 26, 2020)
- Separation Agreement effective January 8, 2020 by and between Revance Therapeutics, Inc. and Caryn G. McDowell (Filed With SEC on February 26, 2020)
- Executive Employment Agreement effective December 1, 2019 and between Revance Therapeutics, Inc. and Dustin Sjuts (Filed With SEC on February 26, 2020)
- Revance Therapeutics, Inc. 2020 Management Bonus Plan (Filed With SEC on February 26, 2020)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 26, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 4, 2019)
- Executive Employment Agreement effective October 13, 2019 by and between Revance Therapeutics, Inc. and Mark J. Foley (Filed With SEC on November 4, 2019)
- Revance Therapeutics, Inc. Executive Severance Benefit Plan, Amended and Restated effective October 13, 2019 (Filed With SEC on November 4, 2019)
- Separation Agreement effective October 11, 2019 by and between Revance Therapeutics, Inc. and L. Daniel Browne (Filed With SEC on November 4, 2019)
- Revance Therapeutics, Inc. Executive Severance Benefit Plan, Amended and Restated Effective February 12, 2019 (Filed With SEC on May 9, 2019)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2019)
- Employment Agreement dated November 7, 2018 by and between Revance Therapeutics, Inc. and Cyril Allouche (Filed With SEC on February 28, 2019)
- Executive Employment Agreement dated November 5, 2018 by and between Revance Therapeutics, Inc. and Tobin Schilke (Filed With SEC on February 28, 2019)
- Revance Therapeutics, Inc. 2019 Management Bonus Plan (Filed With SEC on February 28, 2019)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 28, 2019)
- Executive Employment Agreement dated May 1, 2018 by and between Company and Caryn G. McDowell (Filed With SEC on August 3, 2018)
- Revance Therapeutics, Inc. 2018 Management Bonus Plan (Filed With SEC on March 2, 2018)
- Revance Therapeutics, Inc. Third Amended and Restated Executive Severance Benefit Plan (Filed With SEC on March 2, 2018)
- Executive Employment Agreement by and between the Company and Todd Zavodnick, dated as of September 18, 2017 (Filed With SEC on November 3, 2017)
- Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2017)
- REVANCE THERAPEUTICS, INC. 2017 MANAGEMENT BONUS PROGRAM (Filed With SEC on February 28, 2017)
- REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on February 28, 2017)
- REVANCE THERAPEUTICS, INC. Second Amended and Restated EXECUTIVE SEVERANCE BENEFIT PLAN (Filed With SEC on February 28, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT for Abhay Joshi, PhD, MBA (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. 2016 MANAGEMENT BONUS PROGRAM (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. RESTRICTED STOCK BONUS GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. RESTRICTED STOCK BONUS GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on November 10, 2015)
- REVANCE THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on November 10, 2015)
